PROTOCOL BIOPSIES IN PATIENTS WITH SUBCLINICAL DE NOVO DSA IN KIDNEY TRANSPLANTATION

被引:0
|
作者
Bertrand, D. [7 ]
Jaureguy, M. [1 ]
Garrouste, C. [5 ]
Sayegh, J. [2 ]
Bouvier, N. [4 ]
Caillard, S. [9 ]
Lanfranco, L. [3 ]
Galinier, A. [6 ]
Fancois, A. [7 ]
Hau, F. [8 ]
Etienne, I. [7 ]
Gatault, P. [10 ]
机构
[1] CHU Amiens, Amiens, France
[2] CHU Angers, Angers, France
[3] CHU Brest, Brest, France
[4] CHU Caen, Caen, France
[5] CHU Clermont Ferrand, Clermont Ferrand, France
[6] CHU Poitiers, Poitiers, France
[7] CHU Rouen, Rouen, France
[8] EFS Rouen, Rouen, France
[9] CHU Strasbourg, Strasbourg, France
[10] CHU Tours, Tours, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
O86
引用
收藏
页码:25 / 25
页数:1
相关论文
共 50 条
  • [31] The Frequency of De Novo DSA in the Years Following Heart Transplantation
    Shen, A.
    Patel, J.
    Kittleson, M.
    Chang, D.
    Kransdorf, E.
    Geft, D.
    Nishihara, K.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 761 - 761
  • [32] Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation
    Min, Sang-Il
    Park, Young Suk
    Ahn, Sanghyun
    Park, Taejin
    Do Park, Dae
    Kim, Suh Min
    Moon, Kyung Chul
    Min, Seung-Kee
    Kim, Yon Su
    Ahn, Curie
    Kim, Sang Joon
    Ha, Jongwon
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2012, 83 (06): : 343 - 351
  • [33] MEDIUM TERM OUTCOME OF DE NOVO DSA TREATED WITH OPTIMISED IMMUNOSUPPRESSION FOLLOWING KIDNEY TRANSPLANTATION IN CHILDREN
    Shenoy, Mohan
    Edwards, Liz
    Plant, Nicholas
    Brix, Christian
    Worthington, Judith
    PEDIATRIC NEPHROLOGY, 2023, 38 : S224 - S224
  • [34] The role of hyperleptinaemia and low values of interleukin 10 in de novo DSA production after kidney transplantation
    Dedinska, Ivana
    Kleinova, Patricia
    Machalekova, Katarina
    Granak, Karol
    Vnucak, Matej
    Beliancinova, Monika
    TRANSPLANT IMMUNOLOGY, 2024, 83
  • [35] De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation.
    Garg, N.
    Ellis, T.
    Redfield, R.
    Parajuli, S.
    Astor, B.
    Djamali, A.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 774 - 774
  • [36] Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation
    Bertrand, Dominique
    Kaveri, Rangolie
    Laurent, Charlotte
    Gatault, Philippe
    Jaureguy, Maite
    Garrouste, Cyril
    Sayegh, Johnny
    Bouvier, Nicolas
    Caillard, Sophie
    Lanfranco, Luca
    Thierry, Antoine
    Francois, Arnaud
    Hau, Francoise
    Etienne, Isabelle
    Guerrot, Dominique
    Farce, Fabienne
    PLOS ONE, 2021, 16 (04):
  • [37] Subclinical Antibody Mediated Rejection in Kidney Transplantation: Protocol Biopsy for De Novo Donor Specific Antibody, a Single-Center Experience.
    Bertrand, D.
    Etienne, I.
    Hau, F.
    Guerrot, D.
    Hanoy, M.
    Le Roy, F.
    Legallicier, B.
    Francois, A.
    Godin, M.
    TRANSPLANTATION, 2014, 98 : 436 - 436
  • [38] SCREENING FOR DE NOVO DSA POST-KIDNEY TRANSPLANT IN PATIENTS WITH NORMAL GRAFT FUNCTION
    Nickerson, Peter
    Gibson, Ian
    Pochinco, Denise
    Kelm, Dawn
    Hacking, Kendra
    Blydt-Hansen, Tom
    Rush, David
    HUMAN IMMUNOLOGY, 2009, 70 : S63 - S63
  • [39] EVEROLIMUS BASED IMMUNOSUPPRESSION POSSIBLY SUPPRESS MFI VALUES OF DE NOVO DSA AFTER PRIMARY KIDNEY TRANSPLANTATION
    Narumi, Shunji
    Watarai, Yoshihiko
    Goto, Norihiko
    Hiramitsu, Takahisa
    Tsujita, Makoto
    Okada, Manabu
    Futamura, Kenta
    Tomosugi, Toshihide
    Sakamoto, Shintarou
    Nishihira, Morikuni
    TRANSPLANT INTERNATIONAL, 2019, 32 : 60 - 60
  • [40] Calcineurin Inhibitor Withdrawal is the Significant Risk Factor for De Novo DSA Production in Living Donor Kidney Transplantation
    Hiramitsu, T.
    Tomosugi, T.
    Futamura, K.
    Okada, M.
    Goto, N.
    Narumi, S.
    Uchida, K.
    Watarai, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 849 - 850